EyePoint Pharmaceuticals, Inc. (EYPT) PT Raised to $6 at Laidlaw
Tweet Send to a Friend
Laidlaw raised its price target on EyePoint Pharmaceuticals ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
